Biomarkers are biological markers which can be measured and evaluated to indicate a biological state. The use of biomarkers in research and diagnosis can indicate a normal or disease state or drug response of cells / tissues. Biomarkers include genetic markers, cell surface markers such as antigens, antibodies or receptors and secreted molecules such as cytokines. An assay system is required for identification of biomarkers. :
The MILLIPLEX® MAP Mouse Gut Hormone Panel is used for the simultaneous quantification of the following Mouse analytes: Amylin (Active), GIP (Total), GLP-1 (Active), Ghrelin (Active), Insulin, Leptin, PP, PYY (Total)
The MILLIPLEX® MAP Mouse IGF Binding Protein Panel is used for the simultaneous quantification of the following Human analytes: IGFBP-1, GFBP-2, IGFBP-3, IGFBP-5, IGFBP-6, IGFBP-7
The MILLIPLEX® MAP Mouse IGF Binding Protein Magnetic Bead Panel is used for the simultaneous quantification of the following Human analytes: IGFBP-1, IGFBP-2, IGFBP-3, IGFBP-5, IGFBP-6, IGFBP-7
The MILLIPLEX® MAP Mouse Metabolic Hormone Magnetic Bead Panel is used for the simultaneous quantification of the following Human analytes: Amylin (Active), C-Peptide 2, Ghrelin (Active), GIP (Total), GLP-1 (Active), Glucagon, IL-6, Insulin, Leptin, MCP-1, PP, PYY, Resistin, TNF-α
The MILLIPLEX® MAP EpiQuant™ Phosphotyrosine Cell Signaling Panel 1 is used for the simultaneous quantification of the following Human analytes: Cbl (Tyr700/731/774),Crk (Tyr221/239),CUB domain containing protein 1 (Tyr734), EGFR (Tyr1110/1125), Ezrin (Tyr477), FAK (Tyr397/407), FAK (Tyr861), FRS2 (Tyr436), Fyb (Tyr97/651), Gab1 (Tyr285/307/317), Gab2 (Tyr266), Gab2 (Tyr584), Growth hormone receptor (Tyr566), HER2 (Tyr1023), H…
MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of Epi…
MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of Epi…
MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of Epi…
MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of Epi…
MILLIPLEX® MAP EpiQuant™ technology uses computational algorithms to identify unique, continuous linear sequences (EpiQuant Sequences) in proteins. EpiQuant antibodies generated against EpiQuant sequences have pre-defined target specificity. Protein abundance and/or protein phosphorylation measurements are made at the peptide level, using EpiQuant antibodies, following proteolytic fragmentation of samples and liberation of Epi…
